Acute metabolic studies with trasicor in diabetics.
D000433:1-Propanol / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000097:blood*; D004837:Epinephrine / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005947:Glucose / Q000494:pharmacology; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D008297:Male; D008729:Methoxamine / Q000494:pharmacology; D008875:Middle Aged; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology*; D013997:Time Factors
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011437:Propylamines; D013565:Sympatholytics; D013006:Growth Hormone; D000433:1-Propanol; D011433:Propranolol; D008729:Methoxamine; D005947:Glucose; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine